Xenon Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is …
Biotechnology
CA, Burnaby [HQ]

Balance Sheet

13 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
- - 63.00 54.00 87.00 63.00 67.00 46.00 122.00 147.00 189.00 572.00 754.00 964.00
Current
- - 60.00 49.00 84.00 60.00 65.00 44.00 121.00 144.00 181.00 559.00 600.00 644.00
Non Current
- - 2.00 4.00 2.00 3.00 1.00 1.00 - - 2.00 7.00 12.00 153.00 319.00
Liabilities
- - 50.00 30.00 14.00 2.00 3.00 10.00 19.00 55.00 17.00 21.00 32.00 36.00
Current
- - 19.00 18.00 14.00 2.00 3.00 4.00 4.00 43.00 14.00 14.00 22.00 27.00
Non Current
- - 31.00 12.00 - - - - - - 6.00 15.00 12.00 3.00 7.00 9.00 9.00
Equity
- - 12.00 24.00 72.00 61.00 63.00 35.00 103.00 91.00 171.00 550.00 721.00 927.00
Stockholders' Equity
- - 12.00 24.00 72.00 61.00 63.00 35.00 103.00 91.00 171.00 550.00 721.00 927.00
Retained Earnings
- - -128.00 -116.00 -103.00 -119.00 -142.00 -173.00 -207.00 -249.00 -278.00 -357.00 -482.00 -665.00
Common Stock
- - 6.00 6.00 147.00 148.00 173.00 173.00 265.00 294.00 397.00 783.00 1,065.00 1,436.00
Preferred Stock
- - 102.00 102.00 - - 148.00 173.00 173.00 7.00 7.00 7.00 7.00 - - - -
Profit
-11.00 -4.00 12.00 13.00 -15.00 -22.00 -30.00 -34.00 -41.00 -28.00 -78.00 -125.00 -182.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
- - 29.00 29.00 30.00 -115.00 -138.00 -137.00 38.00 40.00 45.00 117.00 142.00 156.00
Loss Other Compr. Income
- - 3.00 2.00 - - - - - - - - - - - - - - - - -3.00 - -
End of XENE's Analysis
CIK: 1582313 CUSIP: 98420N105 ISIN: CA98420N1050 LEI: - UEI: -
Secondary Listings
XENE has no secondary listings inside our databases.